Celgene reportedly in talks to buy CAR-T cell therapy firm – The Pharma Letter
Investor’s Business Daily |
Celgene reportedly in talks to buy CAR–T cell therapy firm
The Pharma Letter US biotech major Celgene (Nasdaq: CELG) is reportedly looking at what could be its second big acquisition for 2018, and is said to be discussions to purchase US CAR–T cell therapy company Juno Therapeutics (Nasdaq: JUNO) in order to bolster its blood … Juno jumps afterhours as reports suggest Celgene wants a buyout Celgene in talks to buy Juno Therapeutics: WSJ Celgene in Talks to Buy Juno Therapeutics |
